SThree (LON:STEM – Free Report) had its price target boosted by Deutsche Bank Aktiengesellschaft from GBX 260 to GBX 360 in a report issued on Wednesday morning,Digital Look reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.
Separately, Berenberg Bank reissued a “buy” rating and set a GBX 250 price objective on shares of SThree in a research report on Tuesday, July 21st. Two analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of GBX 305.
Check Out Our Latest Analysis on SThree
SThree Price Performance
SThree (LON:STEM – Get Free Report) last announced its earnings results on Tuesday, July 21st. The company reported GBX 2.10 EPS for the quarter. SThree had a net margin of 1.04% and a return on equity of 5.85%. On average, sell-side analysts predict that SThree will post 38.490881 EPS for the current year.
Insider Transactions at SThree
In related news, insider Timo Lehne purchased 20,427 shares of the firm’s stock in a transaction on Wednesday, August 12th. The shares were bought at an average cost of GBX 289 per share, for a total transaction of £59,034.03. 15.69% of the stock is owned by corporate insiders.
SThree Company Profile
SThree plc brings skilled people together to build the future. We are the global STEM workforce consultancy, placing highly skilled, STEM specialist workers in the industries where they are needed most. We advise businesses, build expert teams, and deliver project solutions for our clients. With 40 years of experience in pure-play STEM and a global team with local expertise across 11 countries, we cover high-demand skills across Engineering, Life Sciences and Technology roles.
We provide permanent and flexible contract talent to a diverse base of around 6,000 clients.
Read More
- Five stocks we like better than SThree
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for SThree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SThree and related companies with MarketBeat.com's FREE daily email newsletter.
